logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
P

Piotr Ozierański

university of bath

20H指数
82论文数
1.4K被引数
收录论文 38
发表时间
logo
Pharmaceutical marketing and patient trust: How do doctor-targeted campaigns affect patients?医药营销与患者信任：针对医生的宣传活动如何影响患者？
errPLoS One
IF2.6
err2026-03-27
err0
PREAI
errMakowska, Marta; Ozaki, Akihiko; Ozieranski, Piotr
err分享
err收藏
Quantifying pharmaceutical and medical device industry-physician financial ties: An analysis of honorarium payments to Japanese medical association leadership between 2019 and 2021量化医药和医疗器械行业与医师之间的财务联系：2019年至2021年对日本医学协会领导层酬金支付的分析
errhealth policy
IF3.7
err2025-07-28
err0
PREAI
errAkemi Hara; Tetsuya Tanimoto; Piotr Ozieranski; James Larkin; Michioki Endo; Hiroaki Saito; Akihiko Ozaki
err分享
err收藏
Unknowns of drug company payment disclosure: why the UK needs payment transparency legislation药品公司付款披露的不确定性：为何英国需要付款透明度立法
errBMJ EVIDENCE-BASED MEDICINE
IF7.6
err2025-01-07
err0
PREAI
errOzieranski, P; Rickard, E; Mulinari, S
err分享
err收藏
Pharmaceutical industry payments to healthcare professional organisations in the United Kingdom: a seven-year cross-sectional analysis of the Disclosure UK database from 2015 to 2021
errJOURNAL OF THE ROYAL SOCIETY OF MEDICINE
IF7.1
err2024-11-18
err0
errOAAI
errMurayama, Anju; Fabbri, Alice; Scholfield, Hannah; Ozieranski, Piotr
err分享
err收藏
Drug company methodologies used for reporting in the UK pharmaceutical industry payment transparency database between 2015 and 2019: A content analysis英国制药行业支付透明度数据库2015年和2019中用于报告的制药公司方法: 内容分析
errHEALTH POLICY
IF3.4
err2024-11-01
err0
errOAAI
errLarkin, James; Matthes, Britta; Azribi, Mohamed; Kearns, Conor; Mulinari, Shai; Rickard, Emily; Moriarty, Frank; Fahey, Tom; Ozieranski, Piotr
err分享
err收藏
Pharma pours millions into the NHS for non-research work-but we don't know what the money is being spent on
errBMJ-BRITISH MEDICAL JOURNAL
IF42.7
err2024-10-23
err1
errOAAI
errBoytchev, Hristio; Ozieranski, Piotr; Elsharkawy, Mostafa
err分享
err收藏
Broken beyond repair: self regulation of industry payments to clinicians and hospitals
errBMJ-BRITISH MEDICAL JOURNAL
IF42.7
err2024-07-12
err1
PREAI
errOzieranski, Piotr; Mulinari, Shai
err分享
err收藏
Patterns of company misconduct, recidivism, and complaint resolution delays: A temporal analysis of UK pharmaceutical industry self-regulation within the European context
errREGULATION & GOVERNANCE
IF3.8
err2024-06-20
err3
errOAAI
errMulinari, Shai; Pashley, Dylan; Ozieranski, Piotr
err分享
err收藏
Payments to healthcare organisations reported by the medical device industry in Europe from 2017 to 2019: An observational study欧洲医疗器械行业报告的向医疗机构支付2017年2019年: 一项观察性研究
errhealth policy
IF3.7
err2024-06-01
err5
errOAAI
errLarkin, James; Mulinari, Shai; Ozieranski, Piotr; Lynch, Kevin; Fahey, Tom; Ozaki, Akihiko; Moriarty, Frank
err分享
err收藏
Delays in dealing with complaints against drug companies are growing, BMJ finds
errBMJ-BRITISH MEDICAL JOURNAL
IF42.7
err2024-02-14
err2
errOAAI
errBoytchev, Hristio; Mulinari, Shai; Ozieranski, Piotr
err分享
err收藏
Unethical pharmaceutical marketing: a common problem requiring collective responsibility
errBMJ-BRITISH MEDICAL JOURNAL
IF42.7
err2023-09-19
err8
errOAAI
errMulinari, Shai; Ozieranski, Piotr
err分享
err收藏
Characteristics and Distribution of Scholarship Donations From Pharmaceutical Companies to Japanese Healthcare Institutions in 2017: A Cross-sectional Analysis
errINTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT
IF5.1
err2023-08-21
err5
errOAAI
errMurayama, Anju; Kamamoto, Sae; Saito, Hiroaki; Yamashita, Erika; Suzuki, Yosuke; Tanimoto, Tetsuya; Ozieranski, Piotr; Ozaki, Akihiko
err分享
err收藏
International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency
errGLOBALIZATION AND HEALTH
IF4.5
err2023-03-03
err16
errOAAI
errOzieranski, Piotr; Saito, Hiroaki; Rickard, Emily; Mulinari, Shai; Ozaki, Akihiko
err分享
err收藏
Evaluation of Financial and Nonfinancial Conflicts of Interest and Quality of Evidence Underlying Psoriatic Arthritis Clinical Practice Guidelines: Analysis of Personal Payments From Pharmaceutical Companies and Authors' Self-Citation Rate in Japan and the United States
errARTHRITIS CARE & RESEARCH
IF3.3
err2023-01-14
err19
errOAAI
errMamada, Hanano; Murayama, Anju; Kamamoto, Sae; Kaneda, Yudai; Yoshida, Makoto; Sugiura, Sota; Yamashita, Erika; Kusumi, Eiji; Saito, Hiroaki; Sawano, Toyoaki; Tanimoto, Tetsuya; Vassar, Matt; Ozieranski, Piotr; Ozaki, Akihiko
err分享
err收藏
Advancing international comparison of pharmaceutical industry funding of patient advocacy: Focus on Denmark
errHEALTH POLICY
IF3.4
err2022-12-01
err3
errOAAI
errMulinari, Shai; Pashley, Dylan; Ozieranski, Piotr
err分享
err收藏
Pricing strategies, executive committee power and negotiation leverage in New Zealand's containment of public spending on pharmaceuticals
errhealth economics
IF3.3
err2022-04-06
err7
errOAAI
errMain, Ben; Csanadi, Marcell; Ozieranski, Piotr
err分享
err收藏
Tip of The Iceberg? Country- and Company-Level Analysis of Drug Company Payments for Research and Development in Europe
errINTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT
IF5.1
err2022-03-15
err12
errOAAI
errOzieranski, Piotr; Martinon, Luc; Jachiet, Pierre-Alain; Mulinari, Shai
err分享
err收藏
Disclosure of Pharmaceutical Industry Funding of Patient Organisations in Nordic Countries: Can Industry Self-Regulation Deliver on its Transparency Promise?
errINTERNATIONAL JOURNAL OF HEALTH SERVICES
IF3.1
err2022-03-01
err8
errOAAI
errPashley, Dylan; Ozieranski, Piotr; Mulinari, Shai
err分享
err收藏
Capitalizing on transparency: Commercial surveillance and pharmaceutical marketing after the Physician Sunshine Act利用透明度: 《医师阳光法案》后的商业监督和药品营销
errBIG DATA & SOCIETY
IF5.9
err2022-02-09
err14
errOAAI
errMulinari, Shai; Ozieranski, Piotr
err分享
err收藏
How Do Institutional Conflicts of Interest Between Pharmaceutical Companies and the Healthcare Sector Become Corrupt? A Case Study of Scholarship Donations Between Department of Clinical Anesthesiology, Mie University, and Ono Pharmaceutical in Japan
errFRONTIERS IN PUBLIC HEALTH
IF3.4
err2022-01-03
err10
errOAAI
errOzaki, Akihiko; Murayama, Anju; Harada, Kayo; Saito, Hiroaki; Sawano, Toyoaki; Tanimoto, Tetsuya; Ozieranski, Piotr
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
M
Martin McKee
H 指数: 175 · 论文数: 3.0K
M
Michael West
H 指数: 86 · 论文数: 900
T
Tom Fahey
H 指数: 76 · 论文数: 586
M
Mary Dixon‐Woods
H 指数: 72 · 论文数: 333
R
Richard Baker
H 指数: 71 · 论文数: 729
查看更多